Galectin Therapeutics Inc. (NASDAQ:GALT)

CAPS Rating: 1 out of 5

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

Caps

How do you think GALT will perform against the market?

Add Stock to CAPS Watchlist

All Players

57 Outperform
62 Underperform
 

All-Star Players

7 Outperform
44 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top GALT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

superstar2 (99.45)
Submitted September 30, 2016

This baby is locked and loaded! Sell Off, way, way, overdone! Take advantage!

allstar31 (99.92)
Submitted September 12, 2014

Stock Promoter Pump and dump that uses Redchip.com to fool retail investors into buying. The company was formerly bankrupt and is a con job. Don't buy.

GALT VS S&P 500 (SPY)

Fools bullish on GALT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about GALT.

Recs

0
Member Avatar Bigsef77 (70.06) Submitted: 9/19/2018 11:00:35 AM : Outperform Start Price: $5.81 GALT Score: -12.22

Is the Options Market Predicting a Spike in Galectin Therapeutics (GALT) Stock?
,Zacks•September 18, 2018
Investors in Galectin Therapeutics Inc. GALT need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 21, 2018 $12.00 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Galectin Therapeutics shares, but what is the fundamental picture for the company? Currently, Galectin Therapeutics is a Zacks Rank #3 (Hold) in the Medical - Drugs industry that ranks in the Top 43% of our Zacks Industry Rank. Over the last 60 days, one analyst has increased their earnings estimates for the current quarter, while none analysts have revised the estimate downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from a loss of 11 cents per share to a loss of 10 cents in that period.

Given the way analysts feel about Galectin Therapeutics right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Recs

0
Member Avatar ChiefPaw (23.20) Submitted: 5/16/2018 3:51:04 AM : Underperform Start Price: $4.13 GALT Score: -15.64

Fall like a rock

Recs

2
Member Avatar superstar2 (99.45) Submitted: 9/30/2016 11:29:27 AM : Outperform Start Price: $1.31 GALT Score: +247.06

This baby is locked and loaded! Sell Off, way, way, overdone! Take advantage!

Leaderboard

Find the members with the highest scoring picks in GALT.

Score Leader

farhangp

farhangp (< 20) Score: +733.12

The Score Leader is the player with the highest score across all their picks in GALT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
farhangp < 20 11/7/2016 Outperform 5Y $0.60 +713.74% +32.13% +681.61 0 Comment
dtotino < 20 10/26/2016 Outperform 3Y $0.80 +517.85% +30.92% +486.93 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 70.81 11/10/2016 Outperform 5Y $0.83 +492.24% +29.25% +462.99 0 Comment
dragonLZ 67.99 11/21/2016 Outperform 5Y $0.96 +411.98% +27.88% +384.10 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. superstar2 99.45 9/28/2016 Outperform 5Y $1.31 +276.63% +29.57% +247.06 2 Comments
Under5 < 20 2/15/2017 Outperform 5Y $1.66 +196.08% +20.06% +176.02 0 Comment
cvdynasty 99.93 12/22/2011 Underperform 5Y $6.78 -27.51% +124.89% +152.40 0 Comment
BuffettJunior1 98.47 6/3/2011 Underperform 5Y $7.74 -36.50% +115.35% +151.85 3 Comments
donkeyeffer 99.78 5/23/2011 Underperform 5Y $7.50 -34.47% +112.37% +146.83 0 Comment
stockbullies2 98.44 5/17/2011 Underperform 5Y $7.32 -32.86% +111.04% +143.89 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackascendiantc < 20 10/7/2013 Outperform NS $11.50 -57.26% +67.41% -124.67 0 Comment
trackaegiscorp 34.67 7/26/2012 Outperform NS $2.80 +75.54% +106.26% -30.72 0 Comment
trackglobalhunte < 20 12/19/2011 Outperform NS $5.02 -2.01% +129.62% -131.64 0 Comment

Advertisement